pharmaphorum

APRIL 12, 2022

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The Department of Health, NHS England and NICE have completed an evaluation of two new antibiotics – Pfizer’s Zavicefta (ceftazidime/avibactam) and Shionogi’s Fetcroja (cefiderocol) – that will be paid for using the new subscription-like model likened to a Netflix account.

119

119

Outsourcing Pharma

APRIL 14, 2022

The US agencyâs latest draft document lays out guidelines to help increase involvement of underrepresented ethnic and racial populations in clinical research.

Documentation 98

Documentation FDA 98

Pharma Times

APRIL 11, 2022

Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients

52

52

The Honest Apothecary

APRIL 15, 2022

Mark Cuban. The internet has been all astir for months about the entrance of billionaire Mark Cuban into the pharmacy market with his CostPlus pharmacy model – touted to save consumers money. His mission sounds altruistic enough, and I have even heard some describe his purpose as “philanthropic.” I have no bones to pick with a creative entrepreneur who has found a new way to make a buck.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

APRIL 11, 2022

In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation Fund), pharmaphorum discusses the recent announcement of the closing of a $25 million Series A financing round to scale up the innovative VivoSense® software, which uses wearable sensor data in clinical trials, and for the development of novel digital biomarkers.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Packaging 111

Outsourcing Pharma

APRIL 12, 2022

A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research field.

96

96

Pharmig

APRIL 13, 2022

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post The benefits of training in pharmaceutical microbiology appeared first on Pharmig.

52

52

pharmaphorum

APRIL 11, 2022

GripAble has raised $11 million in first-round financing that will be used to advance its digital health approach to rehabilitation for people with neurological and musculoskeletal conditions on the international stage. The London, UK-based company has developed a platform that combines a hand-held sensor, gamified mobile app software, and telehealth consultations with therapists, which is designed to entertain users while they train at home.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Outsourcing Pharma

APRIL 12, 2022

Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.

88

88

NICE

APRIL 12, 2022

Care models are changing all around us. The significant advancement of digital health technologies and artificial intelligence (AI) capabilities have the potential to revolutionise health and social care. A project within Gloucestershire Hospitals Trust is an excellent example of this. They used machine learning to identify patients at risk of avoidable long-term hospital stays.

Hospitals 52

Hospitals 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Mirror

APRIL 12, 2022

There are so many ways to get into the healthcare industry these days. There are a lot of changes happening in the industry which means that there are a lot of niche services that you can provide and make a lot of money while also serving your communities needs. For instance, telehealth is a burgeoning field these days and is a good place to start. Another area that has a lot of potentials is starting a medical lab facility.

Medical Schools 52

Medical Schools 52

pharmaphorum

APRIL 12, 2022

Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to understand a patient’s prescription journey and who influences prescription-based decisions. The healthcare landscape has shifted dramatically due to the pandemic.

Communication 98

Communication Patient Care FDA 98

Outsourcing Pharma

APRIL 13, 2022

An expert from trial tech specialist Komodo Health talks about how real-world evidence use could elevate study design, conserve costs, and improve recruitment.

52

52

Pharma Marketing Network

APRIL 12, 2022

Tune in to this episode of the Pharma Marketing Podcast for a deeper dive into pharma and modular content, with Ryan Rosenberg, Director Omnichannel Capabilities @ Sanofi , who shared his insights on making modular content work and why pharma is the perfect candidate for it. The post Ep. 21: Pharma & Modular Content: A Deeper Dive appeared first on Pharma Marketing Network.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

APRIL 13, 2022

Cantourage has appointed cannabis prescribers and is now officially operational via a new centre

49

49

pharmaphorum

APRIL 12, 2022

Novartis has joined the select cadre of drugmakers developing KRAS inhibitors for cancer, opening its account with phase 1b data on JDQ443 showing efficacy in KRAS-mutated non-small cell lung cancer (NSCLC). The results – presented at the American Association of Cancer Research (AACR) congress – set Novartis off in pursuit of Amgen, whose Lumakras (sotorasib) is already on the market, and Mirati Therapeutics which has adagrasib under review by the FDA.

FDA 98

FDA 98

Outsourcing Pharma

APRIL 11, 2022

The recruitment tech specialist has added oncology clinical studies to its marketplace, providing sponsors with a larger pool of patients to choose from.

52

52

Med Ed 101

APRIL 13, 2022

I’ve done tons of posts on drug interactions over the years. I’ve dedicated a whole book to drug interactions in primary care AND drug-food interactions. I was recently asked about metoprolol drug interactions and which ones would I consider the most important? Here’s my list of metoprolol drug interactions that I think would be valid […].

45

45

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

APRIL 14, 2022

Approval demonstrates significant step forward in the treatment of adult advanced NSCLC patients with METex14

49

49

pharmaphorum

APRIL 13, 2022

Training can be a bore; dull, predictable sessions shoe-horned into the diary when a meeting room is available or via a virtual session full of muted moments and cross-talk confusion. The pharma industry has turned the microscope of every aspect of its delivery in the face of era-defining shifts caused by the pandemic, and now it is time focus on coaching staff to perform across a new sales and information-sharing landscape.

Communication 98

Communication Hospitals 98

Outsourcing Pharma

APRIL 11, 2022

This monthâs news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

52

52

Berkeley Pharma Tech

APRIL 15, 2022

As of 2022, working within the pharmaceutical sector is one of the best ways to create a meaningful impact on society. Research, development, manufacturing, and prescribing medications are an integral part of the mission of the pharmaceutical industry which is to ultimately enhance the lives of many. There are also a wide variety of rewarding positions available in this field.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Pharma Times

APRIL 11, 2022

The biologics development and manufacturing facility is currently under construction near Oxford, UK

49

49

pharmaphorum

APRIL 14, 2022

The massive backlog in patient care across Europe resulting from the pandemic will take at least three years to clear and in some cases as long as six years, says a new study. The research from Censuswide stems from surveys of oncologists and surgeons across six European countries, which found that 20% of them estimate clearing the backlog will take between four and six years.

Hospitals 78

Hospitals Patient Care 78

Outsourcing Pharma

APRIL 11, 2022

The biomarker developer is partnering with Alzheimer Center Amsterdam on decentralized assessment of patient cognition and function in preclinical research.

52

52

Med Ed 101

APRIL 10, 2022

I started this blog to help educate healthcare professionals all the way back in 2013. It’s hard to believe that I’m approaching 10 years! I can’t thank you all enough for the support. Your purchases have helped me continue to do this blog and podcast while working part-time as a clinical pharmacist. I enjoy giving […]. The post New Release!

40

40

Pharma Times

APRIL 12, 2022

Engetix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD

49

49

pharmaphorum

APRIL 14, 2022

Pfizer’s Australian unit has tabled an offer to buy ResApp Health and its smartphone apps for the management and diagnosis of respiratory diseases in a deal that values the digital health company at around A$100 million (around $75 million). Pfizer is offering A$0.115 per share in cash for ResApp, a deal which has been accepted by the company’s directors and recommended to shareholders ahead of a vote scheduled in June.

75

75

SingleCare

APRIL 14, 2022

Any pharmacy technician will tell you that a day behind the counter is a busy one. Pharmacy techs can’t do every task that pharmacists do, but they handle a whopping list of duties during their long, on-their-feet-all-day shifts. They count pills, call insurance companies, staff the register and the drive-thru, verify insurance coverage, check inventory, and talk to doctor’s offices, all while answering phones, responding to customer questions and complaints, and sometimes even administering vac

Insurance 52

Insurance Insurance Coverage Communication Community Pharmacies 52

pharmaphorum

APRIL 14, 2022

Two years after signing a $3.9 billion alliance with Genmab to find new cancer therapies, AbbVie has said it is ready to start talking to regulators about filing for approval of the lead drug in the partnership – epcoritamab for large B-cell lymphoma (LBCL). The drugmaker has reported top-line results from the phase 1/2 EPCORE trial of epcoritamab as a third-line therapy for relapsed/refractory LBCL, revealing an overall response rate of 63% and a median duration of response of 12 months.

Immunization 64

Immunization 64

pharmaphorum

APRIL 14, 2022

US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its proposed $2.1 million price tag. ICER’s assessment is still at the draft stage and could be changed after an ongoing comment period, but will be welcomed by bluebird and other gene therapy developers as they try to set a price for their one-shot treatments that will be accepted by payers.

FDA 64

FDA 64

pharmaphorum

APRIL 13, 2022

Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen’s oral therapy Vumerity, after NICE recommended the drug for routine NHS use. The decision means that Vumerity (diroximel fumarate) – a follow-up to Biogen’s older oral therapy Tecfidera (dimethyl fumarate) – is now available to eligible patients across the UK, as the Scottish Medicines Consortium approved the drug in February.

Documentation 64

Documentation 64

pharmaphorum

APRIL 13, 2022

An appeals court in California has upheld a lower court ruling that ordered Johnson & Johnson to pay substantial penalties for deceptive marketing of its pelvic mesh implants used to treat conditions like pelvic organ prolapse. J&J and two Ethicon subsidiaries were held by the earlier ruling to have wilfully circulated misleading medical device instructions and marketing communications which “misstated, minimised, and/or omitted the health risks of Ethicon’s…pelvic mesh produ

Communication 59

Communication FDA 59